ABIVAX Stock: Significant Progress Over the Week in a Hesitant Market Environment
ABIVAX stood out with a sharp rise this week, markedly contrasting with the negative trends of the major Parisian indices. While the CAC 40 and SBF 120 lost ground, the French biotech's stock experienced particularly strong momentum. Here's a review of the main movements of the stock and a technical status at the end of the trading week.
Weekly Performance Overview
ABIVAX's stock price closed the week at €102.60, recording a weekly increase of 14.77%. This upward movement is in stark contrast to the declines of the CAC 40 by 3.04% and the SBF 120 by 2.98% over the same period. Over the past month alone, the stock has jumped nearly 35%, following an annual performance of more than 1,100%, far ahead of most French stocks. Trading volumes were particularly high compared to the monthly average, especially during the session on November 20th, where ABIVAX posted the strongest gain at the close in the SBF 120. During this week, prices ranged between €93.30 and €108.60, indicating sustained volatility, while the 50-day moving average (MA50) stands at €81.26 and the MA200 at €36.04. Since the beginning of January, the stock has shown exceptional growth, reaching a historic high of €108.60 and a low of €4.51. The last session, marked by a decline of nearly 5%, followed a strong acceleration the day before (+11.36%).
Technical Analysis
Technically, the stock is currently trading well above its main moving averages, confirming a solidly bullish underlying trend across various timeframes. The immediate support threshold is at €76.10, while the resistance zone is identified at €107.80, close to the weekly high. The stock, which exhibits a monthly volatility of about 19.89%, has a Relative Strength Index (RSI) of 71, indicating an overbought condition. The gap between the current position and the Bollinger Bands (lower at €77.51 / upper at €104.50) illustrates persistent buying pressure while also signaling the stock's deviation from its average levels. Lastly, the MACD indicator displays a positive line at 5.48, indicating a favorable dynamic in price development in the short term.
